
16/07/2023
Medical therapy with warfarin, and more recently with direct oral anticoagulant (DOAC) agents, has historically been the mainstay of therapy for stroke prevention in patients with atrial fibrillation (AF). However, in patients with nonvalvular AF who cannot tolerate long-term oral anticoagulation, l...